Financials
Financial year 2025
LT Pharma from Floreffe, company number BE0662445167, closed financial year 2025 with a result of € 152,451 after tax. For that financial year LT Pharma recorded a gross margin of € 208,046 and equity of € 172,911. Compared with financial year 2023, the result moved from € 122,899 to € 152,451. Profitable, and profit is growing. The buffer shrank hard: equity is 85 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2026.
€ 172,911
▼ 85% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 152,451
▲ 24% vs 2023
Profit after tax over the fiscal year.
€ 191,763
▼ 65% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 879,979 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 2,145
▼ 58% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 439,317
▼ 22% vs 2023
€ 59,907 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 143,945
▲ € 142,521 vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 113,214 | € 182,138 | € 179,422 | € 208,046 | ▲ 16% |
| Profit after taxes | € 74,926 | € 126,852 | € 122,899 | € 152,451 | ▲ 24% |
| Equity | € 867,440 | € 994,292 | € 1,117,191 | € 172,911 | ▼ 85% |
| Total debts | € 702,665 | € 626,590 | € 566,283 | € 1,352,984 | ▲ 139% |
| Cash | € 200,906 | € 561,322 | € 540,978 | € 191,763 | ▼ 65% |
| Retained profit | € 848,840 | € 975,692 | € 1,098,591 | € 154,311 | ▼ 86% |
| Dividend | € 0 | € 0 | € 0 | € 879,979 | |
| Bank debt | € 678,944 | € 619,038 | € 559,808 | € 439,317 | ▼ 22% |
| Balance sheet total | € 1,570,105 | € 1,620,882 | € 1,683,474 | € 1,525,895 | ▼ 9% |
By gross margin, LT Pharma ranks 4th of 5 companies with main activity “Detailhandel in farmaceutische producten” in Floreffe that publish figures (fiscal year 2025).
Key figures of LT Pharma, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about LT Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to LT Pharma?
What happened at LT Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 152,451 (▲ 24% vs 2023). filed late Source: NBB ↗
- New establishment in Floreffe. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 74,926 profit in 2021 to € 152,451 profit in 2025.
Paid € 140,620 in corporate taxes since 2021.
Best year ever: 2025, with € 152,451 profit.
Paid out € 879,979 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Rue de Robersart, Franière 29
5150 Floreffe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Floreffe
Same main activity (Detailhandel in farmaceutische producten), 4 active companies in Floreffe, largest first.
€ 616,259 gross margin · 2025
€ 441,614 gross margin · 2025
€ 297,973 gross margin · 2024
€ 197,472 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- LEDOUX Mathieu Guy(associé) 100%
Details
- Company number
- 0662.445.167
- VAT number
- BE 0662.445.167
- Registered office
- Rue de Robersart, Franière 29, 5150 Floreffe
- Names & denominations
- LT Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 September 2016
- Peppol
- Active · Active since 17 Dec 2025
- Contact
- [email protected] +32486528723
- Activities · NACE
Detailhandel in farmaceutische producten